Dr. Mulsant is a senior scientist with the Adult Neurodevelopment and Geriatric Psychiatry division at CAMH. He is also a professor and the Labatt Family Chair of the Department of Psychiatry and a full member at the Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto.
Dr. Mulsant received his MD from Laval University, Quebec. He completed his internship in internal medicine and neurology at the Royal Victoria Hospital and the Montreal Neurological Institute at McGill University and his residency in psychiatry at the Western Psychiatric Institute and Clinic, University of Pittsburgh. He is a fellow of the Royal College of Physicians and Surgeons of Canada, a diplomate in psychiatry with the American Board of Psychiatry and Neurology, and a distinguished fellow of the American Psychiatric Association.
Areas of Research
The overarching goal of Dr. Mulsant’s work is to improve the treatment of younger and older persons with severe mental disorders. He has designed and conducted clinical trials for “hard–to-treat” older patients with severe mental disorders (including late-life depression, bipolar disorder, psychotic depression, treatment-resistant depression, mild cognitive impairment [MCI], or dementia). He has used these clinical trials of pharmacotherapy, psychosocial interventions, or brain stimulation as platforms to identify biomarkers associated with mental disorders and treatment outcomes.
His current research is supported by Brain Canada to assess the efficacy of cognitive remediation and transcranial direct current stimulation (tDCS) on preventing Alzheimer’s Dementia in older patients with a major depressive disorder in remission or MCI and by the Patient-Centered Outcomes Research Institute (PCORI) to test in a 5-site study the effectiveness of a two-step pharmacotherapy algorithm for bringing about and sustaining remission in older patients with treatment-resistant major depression.
Publications
View Dr. Mulsant’s more than 500 publications on PubMed.